Biomonitoring of possible human exposure to environmental genotoxic chemicals: Lessons from a study following the wreck of the oil tanker braer

Environmental and Molecular Mutagenesis

Volumn 30, Issue 2, 1997, Pages 97-111

  Cole, Jane ^a   Beare, David M ^a   Waugh, Alastair P W ^a   Capulas, Emily ^a   Aldridge, Kay E ^a   Arlett, Colin F ^a   Green, Michael H L ^a   Crum, Jacqueline E ^b   Cox, Derek ^b   Garner, R Colin ^c   Dingley, Karen H ^c   Martin, Elizabeth A ^d   Podmore, Karen ^d   Heydon, Robert ^d   Farmer, Peter B ^d  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b ZE1 0RB   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

32P postlabelling; Braer wreck; Environmental genotoxicity; hprt mutation; Population monitoring

Indexed keywords

ENVIRONMENTAL CHEMICAL; PETROLEUM;

ADULT; ARTICLE; BIOLOGICAL MONITORING; GENOTOXICITY; HUMAN; MALE; MUTATION; POPULATION EXPOSURE;

ACCIDENTS, OCCUPATIONAL; ADULT; AIR POLLUTANTS; DNA ADDUCTS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HEMOGLOBINS; HUMANS; HYDROCARBONS, AROMATIC; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LYMPHOCYTES; MALE; MIDDLE AGED; MUTAGENS; MUTATION; PETROLEUM; PHOSPHORUS RADIOISOTOPES; PILOT PROJECTS; SCOTLAND;

EID: 0030805430     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1997)30:2<97::AID-EM2>3.0.CO;2-9     Document Type: Article

References (39)

1. 32P-postlabelling assay. Carcinogenesis 13:1053-1074.
2. Carrano AV, Natarajan AT (1988): Considerations for population monitoring using cytogenetic techniques. Mutat Res 204:379-406.
3. Claycamp HG (1992): Phenol sensitization of DNA to subsequent oxidative damage in 8-hydroxyguanine assays. Carcinogenesis 13:1289-1292.
4. Cole J, Arlett CF (1994): Cloning efficiency and spontaneous mutant frequency in circulating T-lymphocytes in ataxia-telangiectasia patients. Int J Radiat Biol 66:S123-S131.
5. Cole J, Skopek TR (1994): Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutat Res 304:33-105.
6. Cole J, Green MHL, James SE, Henderson L, Cole H (1988): Human population monitoring: A further assessment of factors influencing measurements of thioguanine-resistant mutant frequency in circulating T-lymphocytes. Mutat Res 204:493-507.
7. Cole J, Arlett CF, Green MHL, James SE, Henderson L, Cole H, Sala-Trepat M, Benzi R, Price ML, Bridges BA (1989): Measurement of mutant frequency to 6-thioguanine resistance in circulating T-lymphocytes for human population monitoring. In Jolles G (ed.): "New Trends in Genetic Risk Assessment." London: Academic Press, pp 175-203.
8. Cole J, Arlett CF, Norris PG, Stephens G, Waugh APW, Beare DM, Green MHL (1992): Elevated hprt mutant frequency in circulating T-lymphocytes of xeroderma pigmentosum patients. Mutat Res 273:171-178.
9. Cole J, Green MHL, Bridges BA, Waugh APW, Beare DM, Henshaw D, Last R, Liu Y, Cortopassi G (1996): Lack of evidence for an association between the frequency of mutants or translocations in circulating lymphocytes and exposure to radon gas in the home. Radiat Res 145:61-69.
10. da Cruz AD, Curry J, Curado MP, Glickman BW (1996): Monitoring hprt mutant frequency over time in T-lymphocytes of people accidentally exposed to high doses of ionizing radiation. Environ Mol Mutagen 27:165-176.
11. Farmer PB, Sepai O, Lawrence R, Autrup H, Sabro Neilsen P, Vestergård AB, Waters R, Leuratti C, Jones NJ, Stone J, Baan RA, van Delft JHM, Steenwinkel MJST, Kyrtopoulos SA, Souliotis VL, Theodorakopoulos N, Bacalis NC, Natarajan AT, Tates AD, Haugen A, Andreassen Å, Øvebrø S, Shuker DEG, Amaning KS, Schouft A, Ellul A, Garner RC, Dingley KH, Abbondandolo A, Merlo F, Cole J, Aldridge K, Beare D, Capulas E, Rowley G, Waugh APW, Povey AC, Haque K, Kirsch-Volders M, Van Hummelen P, Castelain P (1996): Biomonitoring human exposure to environmental carcinogenic chemicals. Mutagenesis 11:363-381.
12. 1-treatment. Cancer Lett 49:7-12.
13. Garner RC, Farmer D, Steele G, Wright A (1991): "Human Carcinogen Exposure: Biomonitoring and Risk Assessment." Oxford: Oxford University Press.
14. Gledhill BL, Mauro F (1991): "New Horizons in Biological Dosimetry." New York: Wiley-Liss.
15. Grant SG, Bigbee WL (1993): In vivo somatic mutation and segregation at the human glycophorin A (GPA) locus: Phenotypic variation encompassing both gene-specific and chromosomal mechanisms. Mutat Res 288:163-172.
16. Green MHL, O'Neill JP, Cole J (1995): Suggestions concerning the relationship between mutant frequency and mutation rate at the hprt locus in human peripheral T-lymphocytes. Mutat Res 334:323-339.
17. Gupta RC (1984): Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci USA 81:6943-6947.
18. 32P-postlabelling analysis of aromatic carcinogen: DNA adducts. Cancer Res 45:5656-5662.
19. 32P-adduct assay: Comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcinogenesis 9:1687-1693.
20. Henderson L, Cole H, Cole J, James SE, Green MHL (1986): Detection of somatic mutations in man: Evaluation of the microtiter cloning assay for T-lymphocytes. Mutagenesis 1:195-200.
21. Jensen RH, Langlois RG, Bigbee WL (1986): Determination of somatic mutations in human erythrocytes by flow cytometry. Prog Clin Biol Res 209B:177-184.
22. Jensen RH, Bigbee WL, Langlois RG (1990): Multiple endpoints for somatic mutations in humans provide complementary views for biodosimetry, genotoxicity and health risks. In Mendelsohn ML, Albertini RJ (eds): "Mutation and the Environment, Part C: Somatic and Heritable Mutation, Adduction, and Epidemiology." New York: Wiley-Liss, pp 81-92.
23. Jolles G, Cordier A (1989): "New Trends in Genetic Risk Assessment." London: Academic Press.
24. Kendall TL, Byerley DJ, Dean R (1991): Isolation of DNA from blood. Anal Biochem 174:74-76.
25. Langlois RG, Akiyama M, Kusunoki Y, DuPont BR, Moore II DH, Bigbee WL, Grant SG, Jensen RH (1993): Analysis of somatic cell mutations at the glycophorin A locus in atomic bomb survivors: A comparative study of assay methods. Radiat Res 136:111-117.
26. Lovell DP (1989): Statistics and genotoxicity testing. In Kirkland DJ (ed): "Statistical Evaluation of Mutagenicity Test Data." Cambridge: Cambridge University Press, pp 1-24.
27. 32P-postlabelled DNA adducts in liver obtained from women treated with tamoxifen. Carcinogenesis 16:1651-1654.
28. 3I postlabeling of released tetraols. Chem Res Toxicol 9:508-516.
29. Mendelsohn ML, Albertini RJ (1990): "Mutation and the Environment, Part C: Somatic and Heritable Mutation, Adduction, and Epidemiology." New York: Wiley-Liss.
30. O'Neill JP, McGinniss MJ, Berman JK, Sullivan LM, Nicklas JA, Albertini RJ (1987): Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis 2:87-94.
31. Payne CD, Atkin M, Baker RJ, Clarke MRB, Francis B, Gilchrist R, Green M, Neider JA, Reese RA, Slater M, Swan AV, White R (1986): The GLIM system, release 3.77. Oxford: Numerical Algorithms Group.
32. 32P-postlabelling of aromatic DNA adducts in white blood cells from iron foundry workers. Mutat Res 204:531-541.
33. 32P-postlabelling test for structurally diverse DNA adducts. Carcinogenesis 7:1543-1551.
34. Robinson DR, Goodall K, Albertini RJ, O'Neill JP, Finett B, Sala-Trepat M, Tates AD, Moustacchi E, Beare D, Green MHL, Cole J (1994): An analysis of in vivo hprt mutant frequency in circulating T-lymphocytcs in the normal human population: A comparison of four data sets. Mutat Res 313:227-247.
35. Roth S, Norppa H, Järventaus H, Kyyrönen P, Ahonen M, Lehtomäki J, Sainio H, Sorsa M (1994): Analysis of chromosomal aberrations, sister-chromatid exchanges and micronuclei in peripheral lymphocytes of pharmacists before and after working with cytostatic drugs. Mutat Res 325:157-162.
36. Sala-Trepat M, Cole J, Green MHL, Rigaud O, Vilcoq JR, Moustacchi E (1990): Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. III: Measurement of mutant frequency to 6-thioguanine resistance. Mutagenesis 5:593-598.
37. Tates AD, Grummit T, van Dam FJ, de Zwart F, Kasper FJ, Rothe R, Stirn H, Zwinderman AH, Natarajan AT (1994): Measurement of frequencies of HPRT mutants, chromosomal aberrations, micronuclei, sister chromatid exchanges and cells with high frequencies of SCEs in styrene/dichloromethane-exposed workers. Mutat Res 313:249-262.
38. Tates AD, Boogaard PJ, Darroudi F, Natarajan AT, Caubo ME, van Sittert NJ (1995): Biological effect monitoring in industrial workers following incidental exposure to high concentrations of ethylene oxide. Mutat Res 329:63-77.
39. van Dam FJ, Camps JA, Woldring VM, Natarajan AT, van der Wall EE, Zwinderman AH, Lohman PHM, Pauwels EKJ, Tates AD (1991): Radionuclide angiography with technetium-99m in vivo labeled erythrocytes does not lead to induction of mutations in the HPRT gene of human T-lymphocytes. J Nucl Med 32:814-819.